Diabetes Technology,Innovation,and the U.S. Health Insurance System

Abstract

The flow of funds in the U.S. health care system is crucial both for the provision of services to patients and to encourage innovation that enables long-term improvement of health services. Rising concern about health care costs often includes concerns about inappropriate adoption of costly or unnecessary technology. Many innovations in diabetes technology may involve personal technology, which does not qualify under existing health insurance categories such as “durable medical equipment” or under a currently defined telehealth technology. In such cases, the diabetes technology industry may be developing types of technology that are so innovative they do not have clearly established payment mechanisms in the existing U.S. fee for service health care reimbursement system. This article describes key features of the U.S. health care payment system relevant to developers of new diabetes technologies.

Keywords

health care reform health insurance managed care Medicare

References

Klonoff

. Twelve modern digital technologies that are transforming decision making for diabetes and all areas of health care. J Diabetes Sci Technol. 2013; 7 (2): 291–5.

Telgener

Lowe

. A look at the current reimbursement environment for continuous glucose monitoring (CGM): Understanding the fundamentals. J Diabetes Sci Technol. 2008; 2 (4): 681–4.

Liles

. Legal and regulatory challenges currently facing diabetes treatment providers and related durable medical equipment suppliers. J Diabetes Sci Technol. 2013; 7 (2): 328–38.

Schäfer

Schnell

Bobáková

. Diabetes device reimbursement in the EU-5. J Diabetes Sci Technol. 2013; 7 (4): 1084–92.

Fuchs

. The gross domestic product and health care spending. N Engl J Med. 2013; 369 (2): 107–9.

Staff of the Washington Post. Landmark: The inside story of America's new health care law and what it means for us all. Washington: Public Affairs; 2010.

Longman

. Best care anywhere: Why VA health care is better than yours. 2nd ed. San Francisco: Berrett-Koehler; 2010.

Frakt

Mayes

. Beyond capitation: How new payment experiments seek to find the ‘sweet spot’ in amount of risk providers and payers bear. Health Aff (Millwood). 2012; 31 (9): 1951–8.

Department Health and Human Services; Centers for Medicare and Medicaid Services. Medicare and Medicaid Programs: Hospital outpatient prospective payment and ambulatory surgical center payment systems and quality reporting programs; hospital value-based purchasing program; organ procurement organizations; quality improvement organizations; electronic health records (EHR) incentive program; provider reimbursement determinations and appeals. Proposed rule. Federal Register. 2013; 78 FR 43533: 43533–707.

10.

U.S. Code of Federal Regulations 42, Part 202.

11.

Centers for Medicare and Medicaid Services. Innovators' guide to navigating Medicare. Ver 2.0. 2010. http://www.cms.gov/Medicare/Coverage/CouncilonTechInnov/Downloads/InnovatorsGuide5_10_10.pdf.

12.

Centers for Medicare and Medicaid Services. HCPCS — General information. http://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/index.html.

13.

Health Care Financing Administration; Department of Health and Human Services. Medicare program; special payment limits for home blood glucose monitors. Final notice. Federal Register. 1995; 60 (10): 3405–10.

14.

Fins

Melo-Martin

. C.P. Snow's “Two Cultures” fifty years later: An enduring problem with an elusive solution. Technology in Society. 2010; 32 (1): 1–4.

15.

Gottlieb

Makower

. A role for entrepreneurs: An observation on lowering healthcare costs via technology innovation. Am J Prev Med. 2013; 44 (1 Suppl 1): S43–7.